6-bromo-1-ethyl-4-methoxy-1H-indole → 2-(6-bromo-1-ethyl-4-methoxy-1H-indol-3-yl)-N,N-dimethyl-2-oxoacetamide
반응식
C(OC1C(F)=CC=C2C=1C([C:19](=[O:25])[C:20]([N:22]([CH3:24])[CH3:23])=[O:21])=CN2)C1C=CC=CC=1.[Br:26][C:27]1[CH:35]=[C:34]2[C:30]([CH:31]=[CH:32][N:33]2[CH2:36][CH3:37])=[C:29]([O:38][CH3:39])[CH:28]=1>>[Br:26][C:27]1[CH:35]=[C:34]2[C:30]([C:31]([C:19](=[O:25])[C:20]([N:22]([CH3:24])[CH3:23])=[O:21])=[CH:32][N:33]2[CH2:36][CH3:37])=[C:29]([O:38][CH3:39])[CH:28]=1참가 물질
3
실험 절차
Following the procedure (step 5, scheme 1) used to prepare compound 1-6a, compound 36-2 gave compound 36-3 (669 mg, 88%) as a pale pink solid. LCMS: calc 352.0 and found: 353.0 [MH]+.
출처 및 근거
- ORD 기록
- ord-28c5eae5db254bf6b3a2f6169226b76b
- 출처 데이터셋
- uspto-grants-2014_12
- 특허 번호
- US08912220B2
반응 노트
불러오는 중…